Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms

Indian Journal of Psychiatry

Volumn 55, Issue 2, 2013, Pages 144-148

  Vahia, Ipsit V ^a,b   Lanouette, Nicole M ^a   Golshan, Shahrokh ^a   Fellows, Ian ^a   Mohamed, Somaia ^c   Kasckow, John W ^d,e   Zisook, Sidney ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California San Diego School of Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Citalopram; depression; negative symptom; schizophrenia

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COVARIANCE; DEPRESSIVE PSYCHOSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84878453983     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.111452     Document Type: Article

References (29)

1. Tempier RP, Pawliuk NH. Conventional, atypical, and combination antipsychotic prescriptions: A 2-year comparison. J Clin Psychiatry 2003;64:673-9.
2. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009;35:383-402.
3. Escamilla MA. Diagnosis and treatment of mood disorders that co-occur with schizophrenia. Psychiatr Serv 2001;52:911-9.
4. Chakos MH, Glick ID, Miller AL, Hamner MB, Miller DD, Patel JK, et al. Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr Serv 2006;57:1094-101.
5. Siris SG, Bermanzohn PC, Mason SE, Shuwall MA. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial. Arch Gen Psychiatry 1994;51:109-15.
6. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. Arch Gen Psychiatry 1987;44:533-9.
7. Joffe G, Terevnikov V, Joffe M, Stenberg JH, Burkin M, Tiihonen J. Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial. Schizophr Res 2009;108:245-51.
8. Kasckow JW, Zisook S. Co-occurring depressive symptoms in the older patient with schizophrenia. Drugs Aging 2008;25:631-47.
9. Whitehead C, Moss S, Cardno A, Lewis G. Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev 2002;2:CD002305.
10. Rummel C, Kissling W, Leucht S. Antidepressants for the negative symptoms of schizophrenia. Cochrane Database Syst Rev 2006;3:CD005581.
11. Mulholland C, Lynch G, King DJ, Cooper SJ. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. J Psychopharmacol 2003;17:107-12.
12. Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, et al. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol 2002;22:20-5.
13. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 2007;68:546-57.
14. Lindenmayer JP, Kay SR. Depression, affect and negative symptoms in schizophrenia. Br J Psychiatry Suppl 1989;155:108-14.
15. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345-51.
16. Silver H, Nassar A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study. Biol Psychiatry 1992;31:698-704.
17. Zisook S, Kasckow JW, Golshan S, Fellows I, Solorzano E, Lehman D, et al. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: A randomized controlled trial. J Clin Psychiatry 2009;70:562-71.
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
19. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.
20. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: The calgary depression scale. Br J Psychiatry Suppl 1993;163:39-44.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
22. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
23. Lykouras L, Oulis P, Psarros K, Daskalopoulou E, Botsis A, Christodoulou GN, et al. Five-factor model of schizophrenic psychopathology: How valid is it? Eur Arch Psychiatry Clin Neurosci 2000;250:93-100.
24. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
25. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992;6:201-8.
26. Diwan S, Cohen CI, Bankole AO, Vahia I, Kehn M, Ramirez PM. Depression in older adults with schizophrenia spectrum disorders: Prevalence and associated factors. Am J Geriatr Psychiatry 2007;15:991-8.
27. Kasckow J, Patterson T, Fellows I, Golshan S, Solorzano E, Mohamed S, et al. Functioning in middle aged and older patients with schizophrenia and depressive symptoms: Relationship to psychopathology. Am J Geriatr Psychiatry 2008;16:660-3.
28. Bankole AO, Cohen CI, Vahia I, Diwan S, Kehn M, Ramirez PM. Factors affecting quality of life in a multiracial sample of older persons with schizophrenia. Am J Geriatr Psychiatry 2007;15:1015-23.
29. Vahia I, Bankole AO, Reyes P, Diwan S, Palekar N, Sapra M, et al. Schizophrenia in later life. Aging Health 2007;3:383-96.